Renal transplant recipients often admitted with acute MI

February 9, 2017

(HealthDay)—Renal transplant recipients (RTRs) are often admitted with acute myocardial infarction (AMI), according to a study published in the Feb. 15 issue of The American Journal of Cardiology.

Sahil Agrawal, M.D., from St. Luke's University Health Network in Bethlehem, Penn., and colleagues examined recent trends in AMI admissions for 9,243 RTRs with functioning grafts. Data were compared to those of 160,932 patients with end-stage renal disease without transplantation (ESRD-NRT) and 5,640,851 patients without advanced kidney disease (non-ESRD/RT) admitted with AMI.

The researchers found that 0.2 percent of AMI admissions were RTRs, with increasing numbers during the study period (adjusted odds ratio [aOR], 1.04; 95 percent confidence interval [CI], 1.04 to 1.05; Ptrend < 0.001). Acute ST-segment elevation (STEMI) accounted for 29.3 percent of RTR admissions. History of renal transplantation correlated with decreased likelihood of STEMI at presentation compared with non-ESRD/RT (aOR, 0.73; 95 percent CI, 0.65 to 0.80; P < 0.001). From 2003 to 2011 there was a decrease in in-hospital mortality among RTRs admitted for non-STEMI (3.8 to 2.1 percent; aOR, 0.85; 95 percent CI, 0.78 to 0.93; P < 0.001), while no change was seen for STEMI (7.6 to 9.3 percent; aOR, 0.97; 95 percent CI, 0.90 to 1.03; P = 0.36). Compared with ESRD-NRT, the rates of percutaneous coronary interventions and in-hospital mortality were lower for RTRs (both P < 0.001).

"RTRs were frequently admitted with AMI, particularly NSTEMI," the authors write.

Explore further: Cumulative incidence of ESRD low in patients with type 1 DM

More information: Full Text (subscription or payment may be required)

Related Stories

Cumulative incidence of ESRD low in patients with type 1 DM

November 8, 2016

(HealthDay)—Patients with type 1 diabetes diagnosed at age 15 to 27 years have low cumulative incidence of end-stage renal disease (ESRD) and increased mortality during long-term follow-up, according to a study published ...

Metabolites linked to renal decline, time to ESRD in T1DM

January 19, 2017

(HealthDay)—Serum levels of seven modified metabolites are associated with renal function decline and time to end-stage renal disease (ESRD) among patients with type 1 diabetes (T1D), according to a study published online ...

Use of evidence-based meds increasing for STEMI, NSTEMI

February 12, 2013

(HealthDay)—Evidence-based therapies are increasingly being used to treat patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI), according to research ...

Short hospital stays don't impair STEMI outcomes in seniors

March 25, 2015

(HealthDay)—For older patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), outcomes are similar for discharge after 48 hours versus four to five days, ...

Recommended for you

Hypertension in young adults shows long-term heart risks

May 19, 2017

Otherwise healthy young people with high systolic blood pressure over 140 are at greater risk for future artery stiffening linked to an increased risk of stroke as well as possible damage to the kidneys and brain, new research ...

Team discovers way to help heart failure patients

May 17, 2017

Shortness of breath is the No.1 complaint of people suffering from heart failure. Now a University of Guelph researcher has discovered its surprising cause - and an effective treatment - in a groundbreaking new study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.